$150.59
2.04% today
NYSE, Apr 04, 09:45 pm CET
ISIN
US23918K1088
Symbol
DVA

DaVita HealthCare Partners Target price 2025 - Analyst rating & recommendation

DaVita HealthCare Partners Classifications & Recommendation:

Buy
8%
Hold
83%
Sell
8%

DaVita HealthCare Partners Price Target

Target Price $169.14
Price $153.73
Potential
Number of Estimates 7
7 Analysts have issued a price target DaVita HealthCare Partners 2026 . The average DaVita HealthCare Partners target price is $169.14. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 1 Analysts recommend DaVita HealthCare Partners to buy, 10 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the DaVita HealthCare Partners stock has an average upside potential 2026 of . Most analysts recommend the DaVita HealthCare Partners stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 12.82 13.49
5.56% 5.27%
EBITDA Margin 20.90% 20.61%
8.14% 1.40%
Net Margin 6.74% 6.61%
36.99% 1.98%

7 Analysts have issued a sales forecast DaVita HealthCare Partners 2025 . The average DaVita HealthCare Partners sales estimate is

$13.5b
Unlock
. This is
5.27% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$13.8b 7.68%
Unlock
, the lowest is
$13.3b 3.76%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $12.8b 5.56%
2025
$13.5b 5.27%
Unlock
2026
$14.0b 3.42%
Unlock
2027
$14.4b 3.33%
Unlock
2028
$15.0b 4.18%
Unlock
2029
$15.5b 2.90%
Unlock

6 Analysts have issued an DaVita HealthCare Partners EBITDA forecast 2025. The average DaVita HealthCare Partners EBITDA estimate is

$2.8b
Unlock
. This is
3.82% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$2.8b 4.79%
Unlock
, the lowest is
$2.7b 2.42%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $2.7b 14.16%
2025
$2.8b 3.82%
Unlock
2026
$2.9b 4.24%
Unlock
2027
$3.0b 3.45%
Unlock

EBITDA Margin

2024 20.90% 8.14%
2025
20.61% 1.40%
Unlock
2026
20.78% 0.82%
Unlock
2027
20.80% 0.10%
Unlock

4 DaVita HealthCare Partners Analysts have issued a net profit forecast 2025. The average DaVita HealthCare Partners net profit estimate is

$892m
Unlock
. This is
3.04% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$952m 9.95%
Unlock
, the lowest is
$858m 0.93%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $864m 44.61%
2025
$892m 3.24%
Unlock
2026
$1.1b 18.21%
Unlock
2027
$1.2b 13.58%
Unlock
2028
$1.4b 14.04%
Unlock
2029
$1.5b 9.61%
Unlock

Net Margin

2024 6.74% 36.99%
2025
6.61% 1.98%
Unlock
2026
7.56% 14.37%
Unlock
2027
8.31% 9.92%
Unlock
2028
9.09% 9.39%
Unlock
2029
9.69% 6.60%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 10.73 11.08
44.61% 3.26%
P/E 13.88
EV/Sales 1.88

4 Analysts have issued a DaVita HealthCare Partners forecast for earnings per share. The average DaVita HealthCare Partners EPS is

$11.08
Unlock
. This is
3.07% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$11.82 9.95%
Unlock
, the lowest is
$10.65 0.93%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $10.73 44.61%
2025
$11.08 3.26%
Unlock
2026
$13.09 18.14%
Unlock
2027
$14.87 13.60%
Unlock
2028
$16.96 14.06%
Unlock
2029
$18.59 9.61%
Unlock

P/E ratio

Current 14.31 23.19%
2025
13.88 3.00%
Unlock
2026
11.74 15.42%
Unlock
2027
10.34 11.93%
Unlock
2028
9.06 12.38%
Unlock
2029
8.27 8.72%
Unlock

Based on analysts' sales estimates for 2025, the DaVita HealthCare Partners stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.98 1.49%
2025
1.88 4.89%
Unlock
2026
1.82 3.31%
Unlock
2027
1.76 3.22%
Unlock
2028
1.69 4.01%
Unlock
2029
1.64 2.82%
Unlock

P/S ratio

Current 0.96 3.78%
2025
0.91 5.00%
Unlock
2026
0.88 3.31%
Unlock
2027
0.85 3.22%
Unlock
2028
0.82 4.02%
Unlock
2029
0.80 2.81%
Unlock

Current DaVita HealthCare Partners Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Barclays
Locked
Locked
Locked Feb 18 2025
Barclays
Locked
Locked
Locked Oct 31 2024
Truist Securities
Locked
Locked
Locked Oct 07 2024
Truist Securities
Locked
Locked
Locked Aug 20 2024
Analyst Rating Date
Locked
Barclays:
Locked
Locked
Feb 18 2025
Locked
Barclays:
Locked
Locked
Oct 31 2024
Locked
Truist Securities:
Locked
Locked
Oct 07 2024
Locked
Truist Securities:
Locked
Locked
Aug 20 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today